The patient had a history of RCC, splenic and mesenteric vein thrombosis, hyperlipidemia, and hypothyroidism and was previously treated with sunitinib, pazopanib, nivolumab, and an experimental glutaminase inhibitor. This evidence concerns the gene GLS and hypothyroidism.